# Boehringer Ingelheim Pharma Gmbh & Co Kg - Inspection Records

Source: https://www.keypedia.com/companies/boehringer-ingelheim-pharma-gmbh-co-kg/5b2ffd33-30ee-4e73-bb66-fa96b4549154

> Inspection records and compliance data for Boehringer Ingelheim Pharma Gmbh & Co Kg in Biberach An Der Ris, None. Access full analysis and detailed observations.

---

## Details

- Name: Boehringer Ingelheim Pharma Gmbh & Co Kg
- FEI Number: 3002806518
- City: Biberach An Der Ris
- State: None
- Country Name: Germany
- Address Line 1: Boehringer Ingelheim Pharma Gmbh & Co. Kg, Birkendorfer Str. 65
- Zip Code: None

## Related Documents

- [FDA Inspection 1208927 - Boehringer Ingelheim Pharma Gmbh & Co Kg - 2022-07-22](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharma-gmbh-co-kg/9de3497b-512b-42a4-ae0e-2d4019f554dd) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 22, 2022
- [FDA Inspection 1102691 - Boehringer Ingelheim Pharma Gmbh & Co Kg - 2019-09-19](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharma-gmbh-co-kg/db6a02f0-3ebc-4c6a-b689-a50299bdaa08) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 19, 2019
- [FDA Inspection 1107587 - Boehringer Ingelheim Pharma Gmbh & Co Kg - 2019-08-15](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharma-gmbh-co-kg/9096c412-3d0c-495a-bc07-117473eca2b6) — classification: No Action Indicated (NAI), source: FDA, date: August 15, 2019
- [FDA Inspection 1086418 - Boehringer Ingelheim Pharma Gmbh & Co Kg - 2019-04-05](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharma-gmbh-co-kg/dbf348fc-bd1b-46d8-8ac0-0e7e2889aa61) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 5, 2019
- [FDA Inspection 881697 - Boehringer Ingelheim Pharma Gmbh & Co Kg - 2014-05-30](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharma-gmbh-co-kg/a2c6cb01-57e6-4c5e-949b-e480008d9ddd) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 30, 2014
- [FDA Inspection 826498 - Boehringer Ingelheim Pharma Gmbh & Co Kg - 2013-03-19](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharma-gmbh-co-kg/b82b9c1c-8e5d-4af2-b32e-7c891abab0fd) — classification: No Action Indicated (NAI), source: FDA, date: March 19, 2013
- [WARNING_LETTER - Boehringer Ingelheim Pharma Gmbh & Co Kg - 2012-11-12](https://www.keypedia.com/records/warning_letter/boehringer-ingelheim-pharma-gmbh-co-kg/04e89218-3e9d-4810-a153-fa6ee72a013f) — source: FDA, date: November 12, 2012
- [FDA Inspection 773781 - Boehringer Ingelheim Pharma Gmbh & Co Kg - 2012-03-13](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharma-gmbh-co-kg/71b9b9eb-6151-4ad3-996b-789f608cff92) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 13, 2012
- [FDA Inspection 670365 - Boehringer Ingelheim Pharma Gmbh & Co Kg - 2010-05-26](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharma-gmbh-co-kg/d6393d4e-690a-46c8-96dd-7a6ebeda66b1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 26, 2010
- [FDA Inspection 647402 - Boehringer Ingelheim Pharma Gmbh & Co Kg - 2010-01-28](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharma-gmbh-co-kg/2b4caea0-7f2a-4269-891d-3a0e8548e48c) — classification: No Action Indicated (NAI), source: FDA, date: January 28, 2010
- [FDA Inspection 599065 - Boehringer Ingelheim Pharma Gmbh & Co Kg - 2009-05-19](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharma-gmbh-co-kg/3e902687-27df-48c1-8d3c-bc8d1a370fde) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 19, 2009

## Related Companies

- [Particle Dynamics LLC](https://www.keypedia.com/companies/particle-dynamics-llc/0fdd4014-06a4-402c-9438-71b62c24f197)
- [Merck Serono SA](https://www.keypedia.com/companies/merck-serono-sa/11522eec-8d30-492a-90ba-09b167899bdc)
- [F. Hoffmann - La Roche Ltd.](https://www.keypedia.com/companies/f-hoffmann-la-roche-ltd/622e8fa3-95f3-4ed9-a1bd-99dc0748f273)
- [Union Agener Inc](https://www.keypedia.com/companies/union-agener-inc/df0cd656-2745-4427-bd39-ebb3bec4ea19)
- [Suven Pharmaceuticals Limited](https://www.keypedia.com/companies/suven-pharmaceuticals-limited/c01306bf-33dc-4f28-a424-11cda764a0d5)
- [Xellia Pharmaceuticals ApS](https://www.keypedia.com/companies/xellia-pharmaceuticals-aps/5d9704ca-114e-4a65-abca-966a5c4e2a57)
- [Bio-Technology General (Israel), Ltd.](https://www.keypedia.com/companies/bio-technology-general-israel-ltd/7e4f2eb9-bacb-4307-9003-5a223c16eed8)
- [Piramal Critical Care, Inc.](https://www.keypedia.com/companies/piramal-critical-care-inc/9cb01f72-bedf-48bc-acb6-d2d9933a3f0f)
- [Roche Diagnostics GmbH](https://www.keypedia.com/companies/roche-diagnostics-gmbh/a23249df-90f8-49fa-8a07-267a69157488)
- [Actavis Elizabeth LLC, A Company of Teva](https://www.keypedia.com/companies/actavis-elizabeth-llc-a-company-of-teva/c4a12fda-d6c3-4ad3-bac5-cc2b5695950e)

## Related Officers

- [Michael D. Smedley](https://www.keypedia.com/people/michael-d-smedley/6bc2c49a-be81-4769-9185-28538aa5c105)